Skip to main content
. 2022 Jun 24;13:93. doi: 10.4103/ijpvm.IJPVM_411_20

Table 5.

Regression analysis of the association of DII with TAC, MDA in the patients and healthy subjects groups

Patients Healthy subjects


Β (95%CI) *P Β (95%CI) *P
Total antioxidant capacity
 Crude Model 0.04 (-1.40, 1.48) 0.952 -2.63 (-4.59, -0.68) 0.009
 Model 1 0.71 (-0.75, 2.17) 0.336 -2.56 (-4.48, -0.63) 0.010
 Model 2 0.92 (-0.57, 2.42) 0.224 -2.38 (-4.34, -0.43) 0.017
 Model 3 0.69(-1.06,2.46) 0.43 -2.41(-4.41,0.42) 0.01
Malondialdehyde
 Crude Model -0.13 (-0.28, 0.02) 0.086 0.15 (0.02, 0.28) 0.028
 Model 1 -0.12 (-0.28, 0.03) 0.124 0.15 (0.02, 0.28) 0.027
 Model 2 -0.10 (-0.26, 0.06) 0.226 0.16 (0.02, 0.30) 0.024
 Model 3 -0.046(-0.23,0.14) 0.6 0.16 (0.02,0.30) 0.02

*P-value is based on linear regression model. Model 1: Adjusted for Age, Sex & Education. Model 2: Adjusted for Age, Sex, Education, physical activity, BMI & SES. Model 3: Adjusted for Age, Sex, Education, physical activity, BMI & SES, energy, taking medication and supplements